Volume 52, Issue 2 pp. 143-148
Full Access

Prevalence and molecular epidemiology of GB virus C/hepatitis G virus infection in Mongolia

Yutaka Kondo

Yutaka Kondo

Second Department of Medicine, Nagoya City University Medical School, Nagoya, Japan

Search for more papers by this author
Masashi Mizokami

Corresponding Author

Masashi Mizokami

Second Department of Medicine, Nagoya City University Medical School, Nagoya, Japan

Second Department of Medicine, Nagoya City University Medical School, Kawasumi, Mizuho, Nagoya 467, Japan===Search for more papers by this author
Tatsunori Nakano

Tatsunori Nakano

Second Department of Medicine, Nagoya City University Medical School, Nagoya, Japan

Search for more papers by this author
Takanobu Kato

Takanobu Kato

Second Department of Medicine, Nagoya City University Medical School, Nagoya, Japan

Search for more papers by this author
Ryuzo Ueda

Ryuzo Ueda

Second Department of Medicine, Nagoya City University Medical School, Nagoya, Japan

Search for more papers by this author
Motokazu Mukaide

Motokazu Mukaide

Center for Molecular Biology and Cytogenesis, SRL, Inc., Tokyo, Japan

Search for more papers by this author
Kazumasa Hikiji

Kazumasa Hikiji

Center for Molecular Biology and Cytogenesis, SRL, Inc., Tokyo, Japan

Search for more papers by this author
Takafumi Ishida

Takafumi Ishida

Department of Anthropology, University of Tokyo, Tokyo, Japan

Search for more papers by this author
Dorjibal Dorjsuren

Dorjibal Dorjsuren

Institute of Biotechnology, Academy of Science, Ulaanbaatar, Mongolia

Search for more papers by this author
Bumbein Dashnyam

Bumbein Dashnyam

Institute of Biotechnology, Academy of Science, Ulaanbaatar, Mongolia

Search for more papers by this author
Tsendsuren Oyunsuren

Tsendsuren Oyunsuren

Institute of Biotechnology, Academy of Science, Ulaanbaatar, Mongolia

Search for more papers by this author

Abstract

We studied the prevalence of GB virus C/hepatitis G virus (GBV-C/HGV) infection among 112 patients with liver disease and 121 blood donors in Ulaanbaatar, Mongolia. Reverse transcription and polymerase chain reaction were employed to detect GBV-C/HGV RNA using the specific primers derived from the 5′-untranslated region (5′-UTR) of the GBV-C/HGV genome. Nucleotide sequences of all positive samples for GBV-C/HGV RNA were determined. The sequences were analyzed by a molecular evolutionary method. Twenty-five (10.7%) of 233 people were positive for GBV-C/HGV RNA. Eight (6.6%), 11 (9.1%), and 30 (24.8%) blood donors were positive for GBV-C/HGV RNA, HBsAg, and anti-HCV, respectively, although 17 (15.2%), 65 (58.0%), and 64 (54.5%) patients with liver disease were positive for each viral marker. The prevalences of GBV-C/HGV RNA, HBV, and HCV in the patients were significantly higher than those in blood donors (P < 0.05). There was no significant difference in the prevalence of anti-HCV among people with and without GBV-C/HGV RNA, while the prevalence of HBsAg among people with GBV-C/HGV RNA was significantly higher than among those without GBV-C/HGV RNA (P < 0.05). The molecular evolutionary tree showed that GBV-C/HGV was a heterogeneous virus and all strains could be divided into 2 types. One is the same phylogenetic type as HGV, and the other is a new type that is different from GBV-C and HGV. J. Med. Virol. 52:143–148, 1997. © 1997 Wiley-Liss, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.